414 related articles for article (PubMed ID: 32432734)
21. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
[No Abstract] [Full Text] [Related]
22. miR-221-5p enhances cell proliferation and metastasis through post-transcriptional regulation of SOCS1 in human prostate cancer.
Shao N; Ma G; Zhang J; Zhu W
BMC Urol; 2018 Mar; 18(1):14. PubMed ID: 29506516
[TBL] [Abstract][Full Text] [Related]
23. miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells.
Zhu C; Li J; Cheng G; Zhou H; Tao L; Cai H; Li P; Cao Q; Ju X; Meng X; Wang M; Zhang Z; Qin C; Hua L; Yin C; Shao P
Mol Cell Biochem; 2013 Jul; 379(1-2):69-75. PubMed ID: 23591597
[TBL] [Abstract][Full Text] [Related]
24. MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2.
Kang NN; Ge SL; Zhang RQ; Huang YL; Liu SD; Wu KM
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8298-8305. PubMed ID: 30556870
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA DANCR accelerates colorectal cancer progression via regulating the miR-185-5p/HMGA2 axis.
Lu W; Huang Z; Wang J; Liu H
J Biochem; 2022 Mar; 171(4):389-398. PubMed ID: 33481014
[TBL] [Abstract][Full Text] [Related]
26. MiR-1299 functions as a tumor suppressor to inhibit the proliferation and metastasis of prostate cancer by targeting NEK2.
Zhang FB; Du Y; Tian Y; Ji ZG; Yang PQ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):530-538. PubMed ID: 30720160
[TBL] [Abstract][Full Text] [Related]
27. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
Song Y; Song C; Yang S
Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
[TBL] [Abstract][Full Text] [Related]
28. LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/HMGA2 axis.
Li WJ; Li G; Liu ZW; Chen ZY; Pu R
Neoplasma; 2021 Nov; 68(6):1225-1235. PubMed ID: 34641698
[TBL] [Abstract][Full Text] [Related]
29. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
[TBL] [Abstract][Full Text] [Related]
30. Role of miR-214-5p in the migration and invasion of pancreatic cancer cells.
Cao TH; Ling X; Chen C; Tang W; Hu DM; Yin GJ
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7214-7221. PubMed ID: 30468464
[TBL] [Abstract][Full Text] [Related]
31. Circ_0001742 promotes tongue squamous cell carcinoma progression via miR-431-5p/ATF3 axis.
Hu YT; Li XX; Zeng LW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10300-10312. PubMed ID: 31841185
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
Xue D; Lu H; Xu HY; Zhou CX; He XZ
J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
[TBL] [Abstract][Full Text] [Related]
33. MiR-150 suppressed cell viability, invasion and EMT via HMGA2 in oral squamous cell carcinoma.
Liu DK; Yu S; Li JP; Song WW; Li JH
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):3981-3989. PubMed ID: 34156675
[TBL] [Abstract][Full Text] [Related]
34. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells.
Lin YC; Lin JF; Tsai TF; Chou KY; Chen HE; Hwang TI
Asian J Surg; 2017 Sep; 40(5):396-406. PubMed ID: 27519795
[TBL] [Abstract][Full Text] [Related]
36. MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer.
Wu ZY; Wang SM; Chen ZH; Huv SX; Huang K; Huang BJ; Du JL; Huang CM; Peng L; Jian ZX; Zhao G
Cancer Biomark; 2015; 15(5):535-42. PubMed ID: 26406941
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13.
Chen L; Hu W; Li G; Guo Y; Wan Z; Yu J
Cell Mol Biol Lett; 2019; 24():20. PubMed ID: 30899277
[TBL] [Abstract][Full Text] [Related]
38. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
[TBL] [Abstract][Full Text] [Related]
39. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer.
Liu J; Li J; Ma Y; Xu C; Wang Y; He Y
Bioengineered; 2021 Dec; 12(1):3240-3251. PubMed ID: 34238129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
